RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 1-8

  Pagel, Paul S ^a   Hettrick, Douglas A ^b   Montgomery, Matthew W ^b   Kersten, Judy R ^b   Steffen, Robert P ^b   Warltier, David C ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EFAPROXIRAL; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL EXPERIMENT; AORTA PRESSURE; ARTICLE; DYSKINESIA; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HYPOTHESIS; NONHUMAN; OXYGEN AFFINITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; REPERFUSION; TONOMETRY;

ANESTHESIA; ANILINE COMPOUNDS; ANIMALS; ANTISICKLING AGENTS; BLOOD PRESSURE; DOGS; FEMALE; HEMODYNAMIC PROCESSES; HEMOGLOBINS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL STUNNING; OXYGEN; PROPIONIC ACIDS;

EID: 0031968729     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Abraham DJ, Peascoe RA, Randad RS and Panikker J (1992a) X-ray diffraction study of di-and tetra-ligated T-state hemoglobin from high salt crystals. J Mol Biol 227:480-492
2. Abraham DJ, Wireko FC, Randad RS, Poyart C, Kister J, Bohn, B, Liard J-F, Kunert MP (1992b) Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-Disubstituted anilinoi)-carboxy]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31:9141-9149.
3. Bolli R (1990) Mechanism of myocardial "stunning". Circulation 82:723-738.
4. Coleman CN (1988) Hypoxia in tumors: A paradigm for the approach to biochemical and physiological heterogeneity. J Natl Cancer Inst 80:310-317.
5. Domenech RJ, Huffman JI, Noble MI, Saunders KB, Henson JR and Subijanto S (1969) Total and regional coronary blood flow measured by radioactive microspheres in conscious and anesthetized dogs. Circ Res 25:581-596.
6. Hartman JC, Olszanski DA, Hullinger TG and Brunden MN (1994) In vivo validation of a transit-time ultrasonic volume flow meter, J Pharmacol Toxicol Methods 31:153-160.
7. Ikebe M. Ara G and Teicher BA (1996) Antimetastatic and radiosensitization effects of the allosteric hemoglobin effector R. S. R.-13. Proc Am Assoc Cancer Res 37:613.
8. 3H mice following administration of an allosteric effector of hemoglobin-oxygen affinity. Radiat Oncol Invest 4:51-59.
9. Khandelwal SR, Randad RS, Lin P-S, Meng H, Pittman RN, Kontos HA, Choi SC, Abraham DJ and Schmidt-Ullrich R (1993) Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am J Physiol 265:H1450-H1453.
10. Kunert MP, Liard J-F and Abraham DJ (1996b) RSR-13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats. Am J Physiol 271:H602-H613.
11. 2 and decreases arteriolar diameter and flow in the rat cremaster muscle. Microvasc Res 52:58-68.
12. Liard JF and Kunert MP (1993) Hemodynamic changes induced by low blood oxygen affinity in dogs. Am J Physiol 264:R396-R401.
13. Mejia MA, Gerstenblith G, Chacko VP, DiPaula AF, Becker LC and Weiss RG (1996) Preservation of high-energy phosphates with an allosteric modifier of hemoglobin-oxygen affinity during low-flow ischemia in the open-chest dog. Circulation 94: Suppl, 1-607.
14. Nicklas JM, Becker LC and Bulkley BH (1985) Effects of repeated brief coronary occlusion on regional left ventricular function and dimension in dogs. Am J Cardiol 56:473-478.
15. Poyart C, Marden MC and Kister J (1994) Bezafibrate derivatives as potent effectors of hemoglobin. Methods Enzymol 232:496-513.
16. Randad RS, Mahran MA, Mehanna AS and Abraham DJ (1991) Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J Med Chem 34: 752-757.
17. Rooke GA and Feigl EO (1982) Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 50:273-286.
18. Wallenstein S, Zucker CL and Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1-9.
19. 2 saturation of hemoglobin on cerebral vasodilation from hypoxia and hypotension. Am J Physiol 265:H1439-H1443.
20. Wireko FC, Kellogg GE and Abraham DJ (1991) Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/ interaction analysis of novel hemoglobin oxygen effectors. J Med Chem 34:758-767.
21. 2 gradients. Adv Exp Med Biol 222:309-313.
22. ATP channels. An endogenous protective mechanism during repetitive ischemia. Am J Physiol 264: H495-H504.